Myelodysplastic Syndromes
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndromes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-12Clinical Trial Results: Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation [NA]
A completed clinical trial evaluating an electronic mindfulness-based music therapy intervention for patients undergoing allogeneic stem cel…
-
CLINICAL_TRIALS trial_result · 2026-07-06Clinical Trial Results: First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) [Phase 1, Phase 2]
First-in-human study results for SAR443579 in relapsed or refractory acute leukemias and BPDCN across Phase 1/2 cohorts; the study was termi…
-
CLINICAL_TRIALS trial_result · 2026-06-17Clinical Trial Results: A Study of E7820 in People With Bone Marrow (Myeloid) Cancers [Phase 2]
Phase 2 trial results for E7820 in myeloid bone marrow cancers have been completed with posted results.
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Results: Recombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Patients Previously Treated With a Hypomethylating Agent [Phase 2]
Phase 2 trial evaluating recombinant EphB4-HSA with azacitidine or decitabine in relapsed/refractory MDS, CMML, or AML after hypomethylating…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors [Phase 1]
A Phase 1 trial evaluating the combination of bortezomib and clofarabine in adults with relapsed solid tumors has been completed. The listed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS) [Phase 2]
Phase 2 trial update evaluating tebapivat (AG-946) for anemia in patients with lower-risk myelodysplastic syndromes. The study is currently …
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Bexmarilimab in combination with standard of care for hematologic malignancies is active but not recru…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial update on epigenetic priming in newly diagnosed acute myeloid leukemia; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders-HEMATO-BIO-IPC-2013-015 [NA]
This clinical trial update reports on predictive clinical and biological parameters across acute leukemia, myelodysplastic syndromes, and my…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL) [Phase 2]
Phase 2 study of fedratinib in myeloproliferative neoplasms, chronic neutrophilic leukemia, and myelodysplastic syndromes; the trial is not …
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: A Phase II Study of Vibecotamab (XmAb14045) for MRD- Positive AML and MDS After Hypomethylating Agent Failure [Phase 2]
A Phase II clinical trial is evaluating Vibecotamab (XmAb14045) for patients with measurable residual disease-positive acute myeloid leukemi…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring [Phase 1]
Phase 1 rollover study by Janssen Research & Development to continue study treatment and ongoing safety monitoring in patients with acute my…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine [Phase 1]
Phase 1 open-label bioavailability study comparing pharmacokinetics of oral cladribine with intravenous cladribine. The study status is TERM…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Gentulizumab in Relapsed/Refractory Acute Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 1]
A Phase 1 study of Gentulizumab in relapsed/refractory acute myeloid leukemia or myelodysplastic syndromes has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS [Phase 1, Phase 2]
Phase 1-2 study of low-dose ASTX727 in lower-risk myelodysplastic syndromes has completed; the trial was sponsored by Taiho Oncology, Inc.
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML) [Phase 1]
Phase 1 clinical trial of CD123-directed T-cell therapy for acute myeloid leukemia and related hematologic diseases is currently recruiting …
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML [Phase 1]
A Phase I open-label dose-escalation study of intravenous INKmune in patients with myelodysplastic syndromes or acute myeloid leukemia was t…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant [Phase 1]
Phase 1 trial of intensity-modulated total marrow irradiation with fludarabine phosphate and melphalan for relapsed hematologic cancers unde…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms [Phase 2]
Phase 2 clinical trial evaluating curcumin to improve inflammation and symptoms in patients with clonal cytopenia of undetermined significan…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Study of Efficacy and Safety of Eltrombopag in Lower-risk MDS Patients With Platelet Transfusion Dependence [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of eltrombopag for lower-risk myelodysplastic syndromes in patients with platele…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML [Phase 1]
Phase 1 study of SL-172154 in acute myeloid leukemia and myelodysplastic syndromes was terminated. Results have been posted on 2026-03-18.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide [Phase 2]
Phase 2 trial evaluating HLA-mismatched unrelated donor hematopoietic cell transplantation with post-transplantation cyclophosphamide is act…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: HLA-mismatched Microtransplantation Without Immunosuppressive Treatment in Patients With Myeloid Hemopathies [Phase 1]
Phase 1 clinical trial update describing the completion of a study evaluating HLA-mismatched microtransplantation without immunosuppressive …
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Ibrutinib and Lenalidomide in Treating Patients With Myelodysplastic Syndrome [Phase 1]
Phase 1 study evaluating the combination of ibrutinib and lenalidomide in myelodysplastic syndromes has completed. The trial included patien…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies [Phase 2]
Phase 2 clinical trial update evaluating TCRαβ-depleted progenitor cell graft with added memory T-cell donor lymphocyte infusion and selecti…